Movement Disorder Society

Movement Disorder Society. The Movement Disorder Society is a professional, international organization of clinicians, scientists, and healthcare professionals dedicated to the study and treatment of Parkinson's disease and other related neurological conditions. Founded in 1985, it has grown to become a leading global authority, promoting research, education, and clinical care to improve the lives of patients worldwide. The society's activities encompass organizing major international congresses, publishing influential scientific journals, and developing critical diagnostic criteria and treatment guidelines.

History

The society was established in 1985 by a group of pioneering neurologists and researchers, including key figures from institutions like the University of Rochester and the National Institutes of Health. Its formation was driven by the growing recognition of movement disorders as a distinct subspecialty within neurology, separate from broader fields like general neurology or psychiatry. Early milestones included the establishment of its official journal and the organization of its first international congress, which helped to consolidate a global community of experts. Over the decades, it has expanded its reach, establishing various special interest groups and regional sections to address specific conditions such as dystonia, Huntington's disease, and Tourette syndrome.

Mission and objectives

The primary mission is to advance research, education, and clinical practice for all movement disorders. Key objectives include fostering the exchange of scientific knowledge through publications and meetings, supporting the professional development of clinicians and researchers worldwide, and advocating for improved patient care standards. A central focus is on creating and validating standardized tools, such as the widely adopted Unified Parkinson's Disease Rating Scale (UPDRS) and its revised version, the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS). The society also aims to bridge the gap between laboratory discoveries and clinical applications, facilitating collaborations with organizations like the World Health Organization and various national Parkinson's disease foundations.

Scientific activities and publications

The society is renowned for its robust scientific output, primarily through its flagship journal, Movement Disorders, a high-impact publication featuring original research and reviews. It also publishes Movement Disorders Clinical Practice, which focuses on practical clinical issues, and the educational journal Movement Disorders - Educational Supplement. Beyond publishing, its scientific committees develop critical consensus statements and clinical practice guidelines, such as those for the diagnosis of Parkinson's disease and the management of dyskinesia. These efforts are often conducted in collaboration with major research entities like the Michael J. Fox Foundation and the National Institute of Neurological Disorders and Stroke (NINDS).

Congresses and events

The organization hosts the premier International Congress, a major biennial event that attracts thousands of delegates from over 100 countries to cities like Copenhagen, Nice, and Hong Kong. This congress features presentations on groundbreaking research, clinical trials, and therapeutic advances for conditions like progressive supranuclear palsy and Wilson's disease. Additionally, it organizes numerous regional congresses, such as the Pan-American and Asian-Oceanian meetings, along with specialized workshops and training programs like the International Parkinson and Movement Disorder Society Summer School. These events serve as vital platforms for networking among experts from institutions like the Mayo Clinic, University College London, and the National Hospital for Neurology and Neurosurgery.

Leadership and governance

Governance is provided by an elected international Executive Committee, which includes the President, President-Elect, Secretary, and Treasurer, who serve defined terms. Notable past presidents include leaders from prestigious centers such as the University of Toronto and the Institute of Neurology, London. The broader leadership structure encompasses various scientific committees, task forces, and the editorial boards of its journals. Key decisions on strategic direction, educational initiatives, and research priorities are made during annual meetings of the International Executive Committee and the Council, which includes representatives from its global membership and affiliated groups like the European Parkinson's Disease Association.

Affiliations and partnerships

The society maintains formal affiliations and collaborative partnerships with numerous international and regional organizations to amplify its impact. These include joint educational initiatives with the American Academy of Neurology and research collaborations with the Parkinson's Foundation. It is a founding member of the International Brain Research Organization (IBRO) and works closely with patient advocacy groups such as the Dystonia Medical Research Foundation. Through these partnerships, it co-sponsors events, contributes to global awareness campaigns like World Parkinson's Day, and participates in policy forums with bodies like the European Medicines Agency (EMA) to influence therapeutic development and regulatory science.